McDonald’s serves up something different at its first Fieldays exhibit
McDonald’s NZ franchise owners exhibit at Fieldays to educate Kiwis about their food supply chain.
recent post
-
Aug 22 2025 -
Aug 22 2025
-
Aug 22 2025
-
Aug 22 2025
-
Aug 22 2025
Thinking About Investing in Penny Stocks? Consider This
If you’re thinking about investing in penny stocks, read the guide here. Learn more about the pros and cons
The Most Exciting Oil And Gas Play On The Planet? Interview with Bill Mooney
As Reconnaissance Energy Africa (TSXV:RECO, OTC:RECAF) continues to excite investors and industry experts alike, we sat down…
Jim Cramer says Yellen’s interest rate comments ‘spooked the market’
The “Mad Money” host said the decline in stocks created an opportunity in steelmaker Nucor, one of the best
Inovalis Real Estate Investment Trust to Pursue “Core+” Strategy and Asset Recycling Program With Renewed Board as Strategic Review Process Concludes
TORONTO–(BUSINESS WIRE)–Inovalis Real Estate Investment Trust (the “REIT”) (TSX:INO.UN) today announced its intention to pursue…
Left-wing teacher holds razor-thin lead in Peru’s presidential election
Far-left trade unionist Pedro Castillo took a razor-thin lead Monday as the final votes were tallied in a neck-and-neck
Could This Household Chemical Become The Superfuel Of The Future?
The hydrogen revolution has had plenty of false starts over the years, but one increasingly popular superfuel may help
Bausch Health Announces Early Tender Results And Early Settlement Date For Cash Tender Offer For Senior Secured Notes
Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health,” the “Company” or the “Offeror”) announced today the results to…
New Alzheimer’s drug approved in U.S. despite concerns about effectiveness – CBC.ca
U.S. government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding…
Big Biogen boost on Alzheimer’s news could win back biotech investors
The approval by U.S. regulators on Monday of a Biogen Inc drug to treat Alzheimer’s disease could reinvigorate investor